Table 4.
Estimated cumulative rate of disease recurrence after pancreatectomy in patients with pancreatic adencarcinoma
| Time after surgery |
Estimated disease-free survival (95% CI) |
||
|---|---|---|---|
| Pancreatic adenocarcinoma (n= 19)a | Pancreatic adenocarcinoma de novo (n= 9)a | Pancreatic adenocarcinoma from IPMN (n= 10) | |
| 6 months | 77% (59–100%) | 47% (21–100%) | 100% (63–100%) |
| 1 year | 56% (26–87%) | 16% (3–93%) | 87% (67–100%) |
| 2 years | 31% (12–83%) | 0% (0–41%) | 70% (40–100%) |
| 3 years | 16% (3–85%) | 0% (0–41%) | 35% (8–100%) |
a
Information regarding disease recurrence was unknown for one pancreatic adenocarcinoma de novo patient.
IPMN, intraductal papillary mucinous neoplasms.